article Insights from discovery through clinical efficacy to support a new class of therapeutics in Alzheimer’s disease 2 June 2017 | By Aidan Power, John A Hey, Martin Tolar, Petr Kocis, Susan Abushakra Research into innovative small molecule therapeutics with disease modifying potential in Alzheimer’s disease (AD) has been conducted at Alzheon since 2013.